This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Elnima, E I Articles by Al-Badr, A A Search for Related Content PubMed PubMed Citation Articles by Elnima, E I Articles by Al-Badr, A A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1981 January; 19(1): 29-32

Antibacterial and antifungal activities of benzimidazole and benzoxazole derivatives.

ABSTRACT

The in vitro antibacterial and antifungal activities of six benzimidazole and benzoxazole derivatives were tested against standard strains and 59 clinical isolates. Of the six compounds, only compounds II and III (both benzoxazoles) were active, whereas the rest were devoid of any activity. Considerable growth inhibition of all of the standard strains, including fungi and gram-positive and gram-negative bacteria, resulted when they were treated with these compounds. Fifty-nine clinical isolates of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were tested for susceptibility to the two compounds. The most susceptible were the S. aureus isolates. The two compounds were of comparable activity against all of the isolates, with compound III showing a slightly higher activity than compound II. Their respective minimal inhibitory concentrations for 90% inhibition of S. aureus were 25 and 50 microgram/ml. The gram-negative bacteria were resistant to the two compounds and required minimal inhibitory concentrations of 200 microgram/ml for a similar degree of inhibition.

This article has been cited by other articles:

• Merino, G., Jonker, J. W., Wagenaar, E., Pulido, M. M., Molina, A. J., Alvarez, A. I., Schinkel, A. H. (2005). TRANSPORT OF ANTHELMINTIC BENZIMIDAZOLE DRUGS BY BREAST CANCER RESISTANCE PROTEIN (BCRP/ABCG2). Drug Metab. Dispos. 33: 614-618 [Abstract] [Full Text]